Humanetics

IN THE PRESS

BioMidwest

Humanetics Receives $3.8 Million from U.S. Department of Defense to Continue Development of Medical Radiation Countermeasures

November 16, 2007

·

1 min read

BioMidwest

Humanetics Receives Orphan Drug Designation for Its BIO 300 Radiation Countermeasure

July 20, 2007

·

1 min read

Drug Development

FDA Clears Humanetics’ IND Filing To Commence Clinical Studies On New Radiation Countermeasure

January 11, 2007

·

1 min read

Drug Development

Humanetics Corporation And Mount Sinai School of Medicine To Begin Clinical Trials Of New Alzheimer’s Compound

March 30, 2006

·

1 min read

JOBS